186 related articles for article (PubMed ID: 38780269)
21. Hypothalamic C2-domain protein involved in MC4R trafficking and control of energy balance.
Gavini CK; Cook TM; Rademacher DJ; Mansuy-Aubert V
Metabolism; 2020 Jan; 102():153990. PubMed ID: 31666192
[TBL] [Abstract][Full Text] [Related]
22. Ion Channels as Therapeutic Targets for Viral Infections: Further Discoveries and Future Perspectives.
Charlton FW; Pearson HM; Hover S; Lippiat JD; Fontana J; Barr JN; Mankouri J
Viruses; 2020 Aug; 12(8):. PubMed ID: 32756358
[TBL] [Abstract][Full Text] [Related]
23. Sensing through Non-Sensing Ocular Ion Channels.
Kabra M; Pattnaik BR
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967234
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetics of infantile nervous system channelopathies.
Gardiner M
Early Hum Dev; 2006 Dec; 82(12):775-9. PubMed ID: 17049761
[TBL] [Abstract][Full Text] [Related]
25. Channelopathies can cause epilepsy in man.
Steinlein OK
Eur J Pain; 2002; 6 Suppl A():27-34. PubMed ID: 11888238
[TBL] [Abstract][Full Text] [Related]
26. [Ion channelopathies and inherited arrhythmia].
Feng MJ; Chu HM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 39(1):97-102. PubMed ID: 20175244
[TBL] [Abstract][Full Text] [Related]
27. Neurological channelopathies: new insights into disease mechanisms and ion channel function.
Kullmann DM; Waxman SG
J Physiol; 2010 Jun; 588(Pt 11):1823-7. PubMed ID: 20375141
[TBL] [Abstract][Full Text] [Related]
28. Genetics and epilepsy.
Steinlein OK
Dialogues Clin Neurosci; 2008; 10(1):29-38. PubMed ID: 18472482
[TBL] [Abstract][Full Text] [Related]
29. Episodic ataxias.
Jen JC; Wan J
Handb Clin Neurol; 2018; 148():521-529. PubMed ID: 29478597
[TBL] [Abstract][Full Text] [Related]
30. Inactivation of UCP1 and the glycerol phosphate cycle synergistically increases energy expenditure to resist diet-induced obesity.
Anunciado-Koza R; Ukropec J; Koza RA; Kozak LP
J Biol Chem; 2008 Oct; 283(41):27688-27697. PubMed ID: 18678870
[TBL] [Abstract][Full Text] [Related]
31. Channeling studies in yeast: yeast as a model for channelopathies?
Wolfe DM; Pearce DA
Neuromolecular Med; 2006; 8(3):279-306. PubMed ID: 16775381
[TBL] [Abstract][Full Text] [Related]
32. Ion channelopathies: a tapped-out mine?
Dudley SC
Am J Physiol Heart Circ Physiol; 2011 Mar; 300(3):H716-7. PubMed ID: 21193585
[No Abstract] [Full Text] [Related]
33. Skeletal-muscle channelopathies: periodic paralysis and nondystrophic myotonias.
Ryan AM; Matthews E; Hanna MG
Curr Opin Neurol; 2007 Oct; 20(5):558-63. PubMed ID: 17885445
[TBL] [Abstract][Full Text] [Related]
34. The neuronal channelopathies.
Kullmann DM
Brain; 2002 Jun; 125(Pt 6):1177-95. PubMed ID: 12023309
[TBL] [Abstract][Full Text] [Related]
35. A mechanism of gap junction docking revealed by functional rescue of a human-disease-linked connexin mutant.
Gong XQ; Nakagawa S; Tsukihara T; Bai D
J Cell Sci; 2013 Jul; 126(Pt 14):3113-20. PubMed ID: 23687377
[TBL] [Abstract][Full Text] [Related]
36. Epileptogenic ion channel mutations: from bedside to bench and, hopefully, back again.
Mantegazza M; Rusconi R; Scalmani P; Avanzini G; Franceschetti S
Epilepsy Res; 2010 Nov; 92(1):1-29. PubMed ID: 20828990
[TBL] [Abstract][Full Text] [Related]
37. Ion channelopathies to bridge molecular lesions, channel function, and clinical therapies.
Carbone E; Mori Y
Pflugers Arch; 2020 Jul; 472(7):733-738. PubMed ID: 32607810
[No Abstract] [Full Text] [Related]
38. Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS.
Santoro B; Chen S; Luthi A; Pavlidis P; Shumyatsky GP; Tibbs GR; Siegelbaum SA
J Neurosci; 2000 Jul; 20(14):5264-75. PubMed ID: 10884310
[TBL] [Abstract][Full Text] [Related]
39. Hypothalamic effects of thyroid hormones on metabolism.
Martínez-Sánchez N; Alvarez CV; Fernø J; Nogueiras R; Diéguez C; López M
Best Pract Res Clin Endocrinol Metab; 2014 Oct; 28(5):703-12. PubMed ID: 25256765
[TBL] [Abstract][Full Text] [Related]
40. Post-translational dysfunctions in channelopathies of the nervous system.
Terragni B; Scalmani P; Franceschetti S; Cestèle S; Mantegazza M
Neuropharmacology; 2018 Apr; 132():31-42. PubMed ID: 28571716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
